CenExel AMRI is seeking adult volunteers diagnosed or at-risk for Preclinical Alzheimer’s Disease to participate in our clinical trials. Alzheimer’s Disease typically begins years or even decades before symptoms manifest, and this stage is called Preclinical Alzheimer’s Disease. Usually, this stage is only identified in research settings like at CenExel AMRI. There will be no noticeable symptoms at this stage, not for the person at-risk for Alzheimer’s Disease or anyone around them.
New imaging technologies can identify specific protein deposits (amyloid-beta) that are common indications of Alzheimer’s disease. Identifying these early protein deposits is especially important to clinical research and future treatments for Alzheimer’s disease. Other Alzheimer’s Disease biomarkers, or indications of an increased risk of disease, may support diagnosis.
CenExel AMRI conducts memory evaluations at no cost to you. This is one of the best ways to determine whether you or your loved one qualifies for a clinical trial at CenExel AMRI, and how to proceed with disease or symptom management.
Memory or other cognitive screenings are essential annual health visits for everyone aged 50 or older for many reasons, including:
- An open discussion about concerns
- A thorough review of medical history
- Review of current medications
- Review of family medical history
- A detailed explanation about memory loss
- Tests to determine if memory problems are present
- An explanation of the options currently available
After a thorough evaluation and review of the results of your no-cost memory screening, you will be notified if you qualify for a clinical trial. Additional screening procedures are required for trials.